|Bid||0.00 x 900|
|Ask||0.00 x 900|
|Day's range||25.33 - 26.59|
|52-week range||22.96 - 79.75|
|Beta (5Y monthly)||1.37|
|PE ratio (TTM)||19.49|
|Earnings date||05 May 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||69.67|
Prothena beats on earnings and revenues in the first quarter of 2022. The company's progress with its AD pipeline is encouraging.
Prothena (PRTA) delivered earnings and revenue surprises of 8.24% and 401.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Prothena (PRTA) has had a phenomenal run in the past year, primarily due to its promising pipeline for AD.